Intermittent fasting in combination with PD-inhibitor treatment as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer

被引:0
|
作者
Haag, Jennifer
Lara, Olivia
Zhou, Chunxiao
Hursting, Stephen D.
Bae-Jump, Victoria
机构
关键词
D O I
10.1158/1557-3265.ENDO24-A008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A008
引用
收藏
页数:2
相关论文
共 28 条
  • [1] Intermittent fasting alone or in combination with paclitaxel as a highly effective treatment strategy in a pre-clinical model of obesity-driven endometrial cancer
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Zhou, Chunxiao
    Lee, Douglas
    Milne, Ginger
    Coleman, Michael
    Shi, Qing
    Sherman, Mark
    Hursting, Stephen
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S38 - S38
  • [2] Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer
    Kong, Weimin
    Deng, Boer
    Shen, Xiaochang
    John, Catherine
    Haag, Jennifer
    Sinha, Nikita
    Lee, Douglas
    Sun, Wenchuan
    Chen, Shuning
    Zhang, Haomeng
    Clontz, Angela
    Hursting, Stephen D.
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2024, 191 : 116 - 123
  • [3] Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer
    Haag, Jennifer
    Deng, Boer
    Shen, Xiaochang
    Sinha, Nikita
    Chen, Shuning
    Zhao, Ziyi
    Clontz, Angela
    Hursting, Stephen
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S18 - S18
  • [4] 2168: Intermittent fasting in combination with carboplatin in a pre-clinical model of obesity-driven endometrial cancer
    Haag, Jennifer
    Lara, Olivia
    Zhou, Chunxiao
    Hursting, Stephen D.
    Bae-Jump, Victoria
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Intermittent fasting was superior to a low-fat diet in impacting tumor growth in a pre-clinical model of obesity-driven endometrial cancer
    Burkett, Wesley
    Zhao, Ziyi
    Zhou, Chunxiao
    Camp, Kristina Kalevas
    Shi, Qing
    Hursting, Stephen
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S80 - S80
  • [6] Intermittent fasting was superior to a low-fat diet in impacting tumor growth in a pre-clinical model of obesity-driven endometrial cancer
    Burkett, Wesley
    Zhao, Ziyi
    Zhou, Chunxiao
    Camp, Kristina Kalevas
    Shi, Qing
    Hursting, Stephen
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 165 : S3 - S3
  • [7] PD-1 inhibitor treatment impacts both immune and metabolic pathways in obesity-driven endometrial cancer
    Staley, A.
    Tucker, K.
    Fang, Z.
    Sun, W.
    Yin, Y.
    Zhang, Y.
    Lee, D.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 48 - 48
  • [8] Clinical and pre-clinical advances in the PDT/PTT strategy for diagnosis and treatment of cancer
    Cuadrado, Coralia Fabiola
    Lagos, Karina J.
    Stringasci, Mirian Denise
    Bagnato, Vanderlei Salvador
    Romero, Maria Paulina
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 50
  • [9] Pre-clinical studies of the therpaeutic effect of a PARP inhibitor combined with radiotherapy for breast cancer treatment
    Pouzoulet, Frederic
    Pernin, Victor
    Roulin, Christophe
    Alcade, Helene
    Assayag, Franck
    Megnin-Chanet, Frederique
    Vaslin-Lepetit, Laurence
    Heinrich, Sophie
    Mahuteau-Betzer, Florence
    Thuleau, Aurelie
    Zaremba, Tomasz
    Favaudon, Vincent
    Marangoni, Elisabetta
    Kirova, Youlia
    Fourquet, Alain
    Hall, Janet
    Decaudin, Didier
    CANCER RESEARCH, 2013, 73 (08)
  • [10] Ipatasertib, an oral AKT inhibitor, in combination with Bevacizumab exhibits anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S31 - S31